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Background: Cynomorium songaricum Rupr. (CS) has been used as a medicine to treat many diseases as well as to
alleviate age-related issues, such as memory impairment, dementia, and stress. In this study, we assessed the effects
of Cynomorium songaricum extract (CSE) on the novel object recognition, cell proliferation and neuroblast differenti-
ation in the dentate gyrus of mice by using 5-bromodeoxyuridine (BrdU) and polysialylated neural cell adhesion
molecule (PSA-NCAM). We also measured serum corticosterone levels to assess its correlation with neurogenesis
and stress.
Methods: Male C57BL/6 J mice were divided into 3 groups: vehicle-treated, 40 mg/kg CSE-treated, and 100 mg/kg
CSE-treated. The vehicle and CSE were given to mice once a day for 3 weeks. BrdU was injected twice a day for 3
days to label newly generated cells.
Results: Administration of CSE significantly increased the preferential exploration of new objects in these mice. In
addition, administration of CSE decreased serum levels of corticosterone. BrdU-positive cells as well as brain-derived
neurotrophic factor (BDNF) mRNA expression in the dentate gyrus were higher in the CSE-treated groups than in
the vehicle-treated group. PSA-NCAM-positive neuroblasts and their well-developed tertiary dendrites were also sig-
nificantly increased by the treatment of CSE. These effects were prominent at the higher dosage than at the lower
dosage.
Conclusion: These results suggest that administration of CSE increases cell proliferation and neuroblast
differentiation in the dentate gyrus of mice by reducing serum corticosterone levels and increasing BDNF levels in
this area.
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Findings of recent research suggest that neurogenesis
occurs throughout the lifetime in the adult mammalian
brain [1-4]. There are 2 discrete neurogenic regions in
the adult brain; the dentate gyrus is one of them [5]. The
dentate gyrus is closely related to learning and memory
[6,7], and it has been reported that hippocampal neuro-
genesis is associated with neurological problems, such as
depression and Alzheimer’s disease [8,9]. In the dentate
gyrus, new neurons are produced from progenitor cells in
the subgranular zone and migrate into the granule cell
layer [2]. Neurogenesis in the adult dentate gyrus is highly
labile [10] and is affected by many exogenous and en-
dogenous factors [11,12].
Cynomorium songaricum Rupr. (CS) is a well-known
root-parasitic plant and is distributed throughout
northwest China [13]. Cynomorium songaricum extract
(CSE) has been widely used as Chinese herbal remedy
for problems such as sexual dysfunction, renal disease,
and lumbar weakness [14]. Moreover, it has been re-
ported that CS induces proliferation of undifferentiated
spermatogonia with glial cell-derived neurotrophic factor
(GDNF) enhancement [15]. Chemically, CS consists of
organic acids, triterpenes, polysaccharides, steroidal
compounds, and flavonoids [16]. CSE has been shown
to suppress age-related learning impairments in aged
flies by reducing hydroperoxide levels and increasing
antioxidants [14]. Among the chemical compounds in
CS, flavonoids have antioxidant effects, and certain
types of flavonoids are involved in neuroprotection andFigure 1 Study design and novel object recognition task. Vehicle or C
for 21 days and BrdU was treated twice a day for 3 days from the day of th
allowed to explore three different objects (A, B and C) for 5 min trials in an
was performed and exploration times were recorded for each object.hippocampal neurogenesis [17-19]. It has also been re-
ported that CSE modulates γ-aminobutyric acid (GABA)
and monoamine transporters, both of which are involved
in hippocampal neurogenesis [13].
Novel object recognition tasks are non-aversive learn-
ing paradigms, which rely on spontaneous exploratory
behavior in experimental animals. Therefore, we investi-
gated the effects of CSE on novel object recognition and
hippocampal neurogenesis by using 5-bromodeoxyuridine
(BrdU) for cell proliferation and polysialylated neural cell
adhesion molecule (PSA-NCAM) for detecting developing
granule neurons in mice. We also measured serum cor-
ticosterone and brain-derived neurotrophic factor (BDNF)




Cynomorium songaricum Rupr. was purchased from
Kyung-dong market (Seoul, South Korea). The plants
were authenticated by two oriental medical doctors and
the voucher specimen was deposited in our laboratory
(deposition number: 2012–028). The plants (100 g) were
chopped and blended using a blender and soaked in 2 L
of 80% ethanol and refluxed at 20°C for 2 h three times.
The insoluble materials were removed through centrifu-
gation at 10,000 × g for 30 min, and the resulting super-
natant was concentrated and freeze-dried to yield a
powder (yield: 13.2%). Before each experiment, the dried
extract was dissolved in distilled and deionized water.SE were orally administered to mice using a feeding needle once a day
e first CSE treatment. At 20 days after CSE treatment, mice were
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Figure 2 Effects of CSE on novel object recognition test.
Preference for exploring novel objects in vehicle-treated, 40 mg/kg
CSE-treated, and 100 mg/kg CSE-treated mice (n= 12 per group;
*P < 0.05, versus vehicle-treated group). Data are presented as the
exploration time for each object (A, B, or C, where C is replaced by D on
the testing day) as a percentage of the total exploration time. On the
training day, the animals do not show preference to explore any
particular object. On the testing day, CSE-treated mice preferentially
explore the novel object D. All data are shown as % exploration ± SEM.
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The progeny of male C57BL/6 J mice were purchased
from the Jackson Laboratory Co. Ltd (Bar Harbor, ME).
Six-week-old mice were used in this study. The mice
were housed in a conventional state under adequate con-
trolled temperature (22°C), humidity (55%), 12-h light/
12-h dark cycle, and provided with free access to food and
tap water. The procedures for the care and handling of an-
imals conformed to guidelines that are in compliance with
current international laws and policies (NIH Guide for the
Care and Use of Laboratory Animals, NIH Publication
No. 85–23, 1985, revised 1996), and the experimental
protocol was approved by the Institutional Animal Care
and Use Committee (IACUC) of Seoul National Univer-
sity (approval no. SNU-110527-2). All of the experiments
were conducted in a way as to minimize the number of
animals used and the suffering caused by the procedures
used in the present study.
Treatment with CSE and BrdU
Mice were randomly divided into the 3 groups: vehicle-
treated group, 40 and 100 mg/kg CSE-treated groups
(n = 12 in each group). Vehicle or CSE were orally ad-
ministered to mice using a feeding needle once a day for
21 days and the animals were sacrificed at immediately
after the novel object recognition test. These schedules
were adopted because PSA-NCAM is a marker for dif-
ferentiated neuroblasts expressed in immature neurons
from only 1 to 21 days of cell age. In order to determine
the integration of new neurons generated in the adult
brain, the animals in the vehicle-treated group (n = 7)
and the 40/100 mg/kg CSE-treated groups (n = 7 in each
group) were treated with 50 mg/kg 5-bromodeoxyuridine
(BrdU, Sigma, St. Louis, MO) twice a day for 3 days from
the day of the first CSE treatment.
Novel object recognition test
At 20 days after CSE treatment, mice (n = 12 in each
group) were placed in an open field and allowed to ex-
plore three different objects (A, B and C) for 5 min trials
and this was repeated once. Object C was replaced by a
novel object (D) 24 h after open field trial and the mice
were allowed to explore for 5 min trial (Figure 1). Explor-
ation times were recorded for each object and expressed
as a percentage of total exploration time.
Blood sampling and measurement of corticosterone
levels
For blood sampling, the animals (n = 12 in each group)
were anesthetized with intraperitoneal injection of 1 g/kg
urethane (Sigma, St. Louis, MO), and blood samples were
collected from each mouse by cardiac puncture before tis-
sue sampling for immunohistochemistry and PCR analysis.
Serum was separated from the blood by centrifugation at1,100 g for 15 min at 4°C and serum (50 μL) was added to
5 mL of methylene chloride and incubated at room
temperature for 10 min. After filtration with cheesecloth,
the mixture was combined with 2.5 mL of fluorescence
reagent (7:3, sulfuric acid/absolute ethanol), vortexed vigor-
ously and incubated for 30 min at room temperature. After
centrifugation, the lower layer was measured using a
spectrophotometer (excited wavelength, 475 nm; emission
wavelength, 530 nm).
Tissue processing for histology
For histology, the animals (n = 7 in each group) were
used after blood sampling. The animals were perfused
transcardially with 0.1 M phosphate-buffered saline (PBS,
pH 7.4) followed by 4% paraformaldehyde in 0.1 M
phosphate-buffer. The brains were removed and postfixed
in the same fixative for 4 h. The brain tissues were cryo-
protected by infiltration with 30% sucrose overnight.
Thirty-μm-thick brain sections in coronal plane were
Figure 3 Effects of CSE on serum corticosterone levels. Serum
corticosterone levels in the vehicle-treated, 40 mg/kg CSE-treated,
and 100 mg/kg CSE-treated groups (n = 12 per group; *P < 0.05, versus
vehicle-treated group). All data are shown as the mean ± SEM.
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The sections were collected into six-well plates containing
PBS for further process.
Immunohistochemistry for BrdU and PSA-NCAM
To obtain the accurate data for immunohistochemistry,
the free-floating sections were carefully processed under
the same conditions. The tissue sections were selected be-
tween −1.46 mm and −2.46 mm posterior to the bregma
in reference to the mouse atlas for each animal [20]. The
sections were sequentially treated with 0.3% hydrogenFigure 4 Effects of CSE on cell proliferation. BrdU immunofluorescence
(B), and 100 mg/kg CSE-treated (C) groups. BrdU-positive cells are significa
treated and 40 mg/kg CSE-treated groups. GCL: granule cell layer; ML: mole
of BrdU-positive cells in the dentate gyrus of the vehicle-treated, 40 mg/kg
*P < 0.05, versus vehicle-treated group; #P < 0.05, versus the 40 mg/kg CSE-peroxide (H2O2) in PBS for 30 min and 10% normal goat
serum in 0.05 M PBS for 30 min. For BrdU immunostain-
ing, DNA was first denatured by incubating the sections
in 50% formamide/2× standard saline citrate at 65°C for
2 h and in 2 N HCL at 37°C for 30 min. They were next
incubated with diluted mouse anti-PSA-NCAM (1:200;
Chemicon, Temecula, CA) or rat anti-BrdU (1:200, Bio-
Source International, Camarillo, CA) overnight at room
temperature and subsequently exposed to biotinylated
goat anti-mouse IgG (1:200; Vector, Burlingame, CA) or
FITC-conjugated anti-rat IgG (1:200; Jackson ImmunoRe-
search, West Grove, PA). For PSA-NCAM staining, the
sections were incubated with streptavidin peroxidase com-
plex (1:200; Vector), visualized with reaction to 3,3’-diami-
nobenzidinetetrachloride (Sigma, St. Louis, MO) in 0.1 M
Tris–HCl buffer (pH 7.2) and mounted on gelatin-
coated slides.
In order to quantitatively analyze BrdU- and PSA-
NCAM-positive cells, 10 sections per animal selected in
the hippocampus at the level of −1.46 to −2.46 mm pos-
terior to the Bregma. BrdU- and PSA-NCAM-positive
cells were calculated using an image analyzing system
equipped with a computer-based CCD camera (software:
Optimas 6.5, CyberMetrics, Scottsdale, AZ). The cell
counts from all of the sections of all of the mice were
averaged.
BDNF mRNA levels in the dentate gyrus
For PCR analysis, the animals (n = 5 in each group) were
used in this study after blood sampling. The dentatein the dentate gyrus of the vehicle-treated (A), 40 mg/kg CSE-treated
ntly higher in the 100 mg/kg CSE-treated group than in the vehicle-
cular layer; PoL: polymorphic layer. Scale bar = 50 μm. D: The number
CSE-treated, and 100 mg/kg CSE-treated groups (n = 7 per group;
treated group). All data are shown as the mean ± SEM.
Figure 5 Effects of CSE on neuroblast differentiation. PSA-NCAM immunohistochemistry in the dentate gyrus of the vehicle-treated (A, B),
40 mg/kg CSE-treated (C, D), and 100 mg/kg (E, F) CSE-treated groups. Compared with the vehicle-treated group, the CSE-treated group shows a
higher number of PSA-NCAM-immunoreactive neuroblasts with well-developed dendrites. GCL: granule cell layer; ML: molecular layer; PoL:
polymorphic layer. Scale bar = 50 μm (A, C, and E), 25 μm (B, D, and F). G: The number of PSA-NCAM-positive neuroblasts in the dentate gyrus
of the vehicle-treated, 40 mg/kg CSE-treated, and 100 mg/kg CSE-treated groups (n = 7 per group; *P < 0.05, versus vehicle-treated group). All data
are shown as the mean ± SEM.
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tion was performed using a total RNA isolation kit
(Macherney-Nagel). Spectrophotometric measurements
were conducted using the Nanodrop Spectrophotom-
eter (Nanodrop Technologies Wilmington, DE, USA) to
determine RNA concentration and purity. A high cap-
acity cDNA archive kit (Applied Biosystems) was used
to reverse transcribe the equalized RNA samples. Quan-
titative real-time PCR (qPCR) was performed with50 ng cDNA using custom-designed gene-expression
assays for BDNF.
Gene expression of targets was assessed using Taqman
gene expression assays (Applied Biosystems, UK) contain-
ing specific target primers, and FAM-labeled MGB target
probes. β-actin gene expression was used to normalize
gene expression between samples, and was quantified
using a β-actin endogenous control gene expression assay
containing specific primers, and a VIC-labeled MGB
Figure 6 Effects of CSE on BDNF mRNA expression. BDNF mRNA
expression in the dentate gyrus of the vehicle-treated, 40 mg/kg
CSE-treated, and 100 mg/kg CSE-treated groups as assessed by
quantitative PCR (n = 5 per group; *P < 0.05, versus vehicle-treated
group). BDNF mRNA expression in the dentate gyrus is higher in the
CSE-treated groups than in the vehicle-treated group. All data are
shown as the ratio to vehicle-treated group ± SEM.
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ΔΔCT method. The primers used were as follows: 5′-
GTGACAGTATTAGCGAGTGGG −3′ (forward) and 5′-
CTAGGGCGGCCCACGATGGA-3′ (reverse) for BDNF
and 5’-GCACCACACCTTCTA CAATG-3′ (forward)
and 5′-TGCTTGCTGATCCACATCTG-3′ (reverse) for
β-actin.
Statistical analysis
The data shown here represent the means of experi-
ments performed for each experimental area. Differences
among the means were statistically analyzed by one-way
analysis of variance followed by Tukey’s multiple range
method in order to elucidate differences between the
vehicle- and CSE-treated groups.
Results
Effects of CSE on object recognition
During the training period, all groups spent a similar
fraction of time exploring the 3 different objects. In
addition, there were no significant changes in total ex-
ploration time. During the testing period, vehicle-treated
mice showed significant increases in the amount of time
spent exploring object D. The administration of CSE sig-
nificantly increased the time spent exploring object D in
a dose-dependent manner and the time spent exploring
object D in 100 mg/kg CSE-treated group was signifi-
cantly increased compared to that in the vehicle-treated
group (Figure 2).
Effects of CSE on serum corticosterone levels
To elucidate the possible mechanism of CSE action on
neurogenesis, serum corticosterone levels were mea-
sured in each group. In the vehicle-treated group, mean
serum corticosterone was 24.8 μg/dL. In the 40 mg/kg
CSE-treated group, mean serum corticosterone level was
17.8 μg/dL, which was significantly lower than that in
the vehicle-treated group. In the 100 mg/kg CSE-treated
group, mean serum corticosterone level was 15.4 μg/dL,
which indicated that the reduction was dose-dependent
(Figure 3).
Effects of CSE on cell proliferation
Immunohistochemical staining for BrdU was performed
to confirm the effect of CSE on cell proliferation in the
dentate gyrus (Figure 4). In the vehicle group, a few
BrdU-positive cells were detected in the dentate gyrus
(Figure 4A). Compared to the vehicle-treated group, the
40 mg/kg CSE-treated group showed little difference in
the number of BrdU-positive cells (Figure 4B). However,
the number of BrdU-positive cells in the dentate gyrus
was significantly higher in the 100 mg/kg CSE-treated
group than in the vehicle-treated and 40 mg/kg CSE-
treated groups (Figure 4C and D).Effects of CSE on neuroblast differentiation
To observe neuroblast differentiation in the subgranular
zone of mouse dentate gyrus, we performed immunohis-
tochemical staining using antibody against PSA-NCAM
(Figure 5). In the vehicle-treated group, PSA-NCAM-
positive neuroblasts with poorly developed dendrites
were noted in the subgranular zone (Figure 5A and B).
The number of PSA-NCAM-positive neuroblasts was sig-
nificantly higher in the 40 and 100 mg/kg CSE-treated
groups than in the vehicle-treated group. Moreover, these
neuroblasts had well-developed dendrites extending to the
molecular layer (Figure 5C, D, E, F, and G).Effects of CSE on BDNF mRNA expression
To investigate the possible mechanisms underlying the
observed cognitive improvements, we tested the dentate
gyri of mice for BDNF expression. BDNF mRNA expres-
sion in the 40 and 100 mg/kg CSE-treated groups was sig-
nificantly increased by 1.40 and 1.49 folds compared to
that in the vehicle-treated group, respectively (Figure 6).Discussion
In the present study, we observed the behavioral prefer-
ences of mice to novel objects after CSE treatment; this
behavioral paradigm exploits the ability of the mice to
explore novel objects over familiar ones during simul-
taneous presentation and has been employed to evaluate
recognition memory [21]. During training periods, mice
in all groups did not show any preferences among the 3
different objects. However, during the test periods, CSE-
treated mice showed strong preferences for the novel ob-
ject, while vehicle-treated mice displayed a much lesser
preference for it. The result of the behavioral test is
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expression measured in this study.
We checked serum corticosterone and BDNF mRNA
levels to elucidate the possible mechanisms for hippo-
campal neurogenesis. CSE treatment decreased serum
corticosterone levels in general, and the corticosterone
level in the 100 mg/kg CSE-treated group was lower than
that in the 40 mg/kg CSE-treated group. It has been re-
ported that corticosteroid hormones regulate the prolifer-
ation, survival, and death of granule cells in the dentate
gyrus [22-24]. Additionally, corticosterone is known to be
associated with cognitive impairment and has detrimental
effects on LTP in the dentate gyrus [25-27]. Moreover,
corticosterone acts on hippocampal BDNF expression
through the exon IV promoter [28], which is required for
the enhancement of hippocampal neurogenesis [29].
Next, we morphologically observed the effects of CSE
on cell proliferation and neuroblast differentiation in the
dentate gyrus. Treatment with CSE increased both BrdU-
positive cells and PSA-NCAM-positive neuroblasts. These
neuroblasts displayed well-developed dendrites, indicating
that CSE may be involved in neuroblast maturation.
Therefore, treatment with CSE can possibly modulate syn-
aptic plasticity by increasing cell proliferation and neuro-
blast differentiation in the subgranular zone of the dentate
gyrus. It has been reported that functional and morpho-
logical changes in the synapse induce altered neuronal
plasticity in the mammalian brain [30,31]. Additionally,
CSE is known to act as an inhibitor of serotonin and
GABA transporters, both of which are crucial for limiting
monoaminergic and GABAergic activity [13,32,33]. GABA
is the principal inhibitory neurotransmitter in the brain
and plays an important role in CNS development and
plasticity [34], and serotonin is an important modulator of
hippocampal neurogenesis [35]. GABA also significantly
increases recognition and working memory in rats [36].
Administration of CSE significantly increased BDNF
mRNA expression in the dentate gyrus homogenates.
BDNF, synthesized locally in the dendrites of granule cells,
promotes differentiation and maturation of progenitor
cells in the subgranular zone of dentate gyrus by enhan-
cing GABA release [37]. Here, the increase of tertiary den-
drites of the neuroblasts, stained with PSA-NCAM, may
be associated with BDNF increase in the dentate gyrus.
Recently, many researchers have explored the mechan-
ism of action and function of CSE in the brain. CSE has
been shown to attenuate Aβ-induced cell death and pro-
tect against superoxide anion-induced cell death [38,39].
In addition, CSE exhibits anti-aging effects by increasing
telomere length in the brain of the D-galactose-induced
aging mice [40]. In this study, we confirmed that CSE
administration influences hippocampal neurogenesis and
cognitive memory by changing BDNF and serum cor-
ticosterone levels.Conclusion
Treatment with CSE significantly increased preference
for the novel object in the novel object recognition test
and enhanced hippocampal neurogenesis in the mouse
dentate gyrus. Changes of the BDNF and serum cortico-
sterone levels were also detected and may be closely
associated with novel object recognition and hippocam-
pal neurogenesis. These results suggest that CSE has the
potential for enhancing hippocampal plasticity and can
be used to people who have problems in hippocampal
memory.
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